Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti tumour-drugs

International Journal of Molecular Medicine

Volumn 23, Issue 1, 2009, Pages 33-39

  Sioud, Mouldy ^a   Boudabous, Abdellatif ^b   Cekaite, Lina ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF TUNIS   (Tunisia)

Author keywords

Anti tumour drugs; Antibiotics; Bacillus subtillis; DNA; DNA supercoiling; Microarray; SOS response; Thuringiensis; Topoisomerases

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; ETOPOSIDE; LEXA PROTEIN; NOVOBIOCIN; PROTEIN DINB; PROTEIN TOPA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING);

ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BACILLUS THURINGIENSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; GENE REPRESSION; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; ANIMAL; CHEMISTRY; DNA REPAIR; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PLASMID;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACILLUS SUBTILIS; BACILLUS THURINGIENSIS; CIPROFLOXACIN; DNA; DNA GYRASE; ETOPOSIDE; GENE EXPRESSION REGULATION; NOVOBIOCIN; PLASMIDS; SOS RESPONSE (GENETICS); TRANSCRIPTION, GENETIC;

EID: 61749084698     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000098     Document Type: Article

References (23)

1. Champoux JJ: DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70: 369-413, 2001.
2. Forterre P, Gribaldo S, Gadelle D and Serre M-C: Origin and evolution of DNA topoisomerases. Biochimie 89: 427-446, 2007.
3. Hooper DC: Mechanisms of action of antimicrobials: focus on fluoroquiolones. Antimicrob Activity 32: S9-S15, 2001.
4. Burden DA and Osheroff N: Mechanism of action of eukaryotic topoisomerases and topoisomerase II and drug targeted to the enzyme. Biochem Biophys Acta 1400: 139-154, 1998.
5. Chen GL, Yang L, Rowe TC, Halligan BD, Tewey KM and Liu LF: Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J Biol Chem 259: 13560-13566, 1984.
6. Mosesso P, Darroudi F, Van Den Berg M, Vermeulen S, Palitti F and Natarajan AT: Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP16, using conventional Giemsa staining and chromosome painting techniques. Mutagenesis 13: 39-43, 1998.
7. Sioud M, Possot O, Elie C, Sibold L and Forterre P: Coumarin and quinolone action in archaebacteria: Evidence for the presence of a DNA gyrase-like enzyme. J Bacteriol 170: 946-953, 1988.
8. Sioud M, Baldacci G, Forterre P and de Recondo AM: Antitumor drug inhibit the growth of halophilic archaebacteria. Eur J Biochem 169: 231-236, 1987.
9. Woese CR: Bacterial evolution. Microbiol Rev 51: 221-227, 1987.
10. Sioud M and Forterre P: Ciprofoxacin and etoposide (VP16) produce a similar pattern of DNA cleavage in a plasmid of an Archaebacterium. Biochem 28: 3638-3641, 1989.
11. Sioud M, Forterre P and de Recondo AM: Effects of the antitumor drug VP16 (etoposide) on the archaebacterial Halobacterium GRB 1.7 kb plasmid in vivo. Nucleic Acids Res 15: 8217-8234, 1987.
12. Cherif A, Ouzari H, Daffonchio D, Cherif H, Ben Slama K, Hassen A, Jaoua S and Boudabous A: Thuricin 7: a novel bacteriocin produced by Bacillus thuringiensis BMG1.7, a new strain isolated from soil. Lett Appl Microbiol 32: 243-247, 2001.
13. Cherif A, Chehimi S, Limem F, Hansen BM, Hendriksen NB, Daffonchio D and Boudabous A: Detection and characterization of the novel bacteriocin entomocin 9, and safety evaluation of its producer, Bacillus thuringiensis ssp. Entomocidus HD9. J Appl Microbiol 95: 990-1000, 2003.
14. Cekaite L, Furset G, Hovig E and Sioud M: Gene expression analysis in blood cells in response to unmodified and 2′-modified siRNAs reveals TLR-dependent and independent effects. J Mol Biol 365: 90-108, 2007.
15. The R Project for Statistical Computing (http://www.rproject.org).
16. TM4 microarray software suite (http://www.tm4.org/).
17. Scheer M, Klawonn F, Munch R, Grote A, Hiller K, Choi C, Koch I, Schobert M, Hartig E, Klages U and Jahn D: JProGO: a novel tool for the functional interpretation of prokaryotic microarray data using Gene Ontology information. Nucleic Acids Res 34(Web Server issue):W510-W515, 2006.
18. Travers A and Muskhelishvili G: A common topology for bacterial and eukaryotic transcription initiation? EMBO Rep 8: 147-151, 2007.
19. Jeong KS, Xie Y, Hiasa H and Khodursky AB: Analysis of pleiotropic transcriptional profiles: a case study of DNA gyrase inhibition. PLoS Genet 2: 1464-1476, 2006.
20. Gmuender H, Kuratli K, Di Padova K, Gray CP, Keck W and Evers S: Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis. Genome Res 11: 28-42, 2001.
21. Au N, Kuester-Schoeck E, Mandava V, Bothwell LE, Canny SP, Chachu K, Colavito SA, Fuller SN, Groban ES, Hensley LA, O'Brien TC, Shah A, Tierney JT, Tomm LL, O'Gara TM, Goranov AI, Grossman AD and Lovett CM: Genetic composition of the Bacillus subtilis SOS system. J Bacteriol 187: 7655-7666, 2005.
22. Kidane D, Sanchez H, Alonso JC and Graumann PL: Visualization of DNA double-strand break repair in live bacteria reveals dynamic recruitment of Bacillus subtilis RecF, RecO and RecN proteins to distinct sites on the nucleoids: Mol Microbiol 52: 1627-1639, 2004.
23. Sioud M, Baldacci G, de Recondo AM and Forterre P: Novobiocin induces positive supercoiling of small plasmids from halophilic archaebacteria in vivo. Nucleic Acids Res 16: 1379-1391, 1988.